The amount of bio-medical data available on the Web grows exponentially with time. The resulting large volume of data makes manual exploration very tedious. Moreover, the velocity at which this data changes and the variety of formats in which bio-medical data is published makes it difficult to access them in an integrated form. Finally, the lack of an integrated vocabulary makes querying this data more difficult.In this paper, we advocate the use of Linked Data to integrate, query and visualize bio-medical data. The resulting Big Linked Data allows discovering knowledge distributed across manifold sources, making it viable for the serendipitous discovery of novel knowledge. We present the concept of Big Linked Data by showing how the constant stream of new bio-medical publications can be integrated with the Linked Cancer Genome Atlas dataset (TCGA) within a virtual integration scenario. We ensure the scalability of our approach through the novel TopFed federated query engine, which we evaluate by comparing the query execution time of our system with that of FedX on Linked TCGA. Then, we show how we can harness the value hidden in the underlying integrated data by making it easier to explore through a user-friendly interface. We evaluate the usability of the interface by using the standard system usability questionnaire as well as a csutomized questionnaire designed for the users of our system. Our overall result of 77 suggests that our interface is easy to use and can thus lead to novel insights.
Introduction
Over the last years, the number of Linked Data sources published has grown to comprise more than 60 billion triples. 1 The portion of these data sources that pertain to bio-medicine is distributed across 5 partly very large datasets. One of the newest addition to the bio-medical datasets is the Linked TCGA [1] , a 20 billion-triple dataset which represents the Cancer Genome Atlas (TCGA) database in RDF. Making bio-medical datasets available as 10 Linked Data presents the obvious advantage of easing their integration and fusion. These integrated datasets can then be used to support bio-medical experts during the analysis and exploration of biomedical knowledge as well as for the extraction of 15 novel knowledge from this data. Moreover, the provision of bio-medical data in RDF allows the use of the powerful query language SPARQL, which eases the selection of relevant portions of the data.
In this paper, we present a scalable framework 20 that aims to support the serendipitous discovery of bio-medical hypotheses from Big Linked biomedical data by providing an interface for the analysis and exploration of Big Linked Data, i.e., large volumes of Linked Data that were extracted from 25 different sources and are updated frequently. The back-end of our application supports the management and querying of high volumes of Linked Data as well as the continuous integration of this data with other novel bio-medical data from external data streams. In this paper, we consider a subset of the Linked TCGA dataset (i.e., 10 tumors) that pertains to various cancer types and its continuous integration with the RDF data extracted from the semi-structured content of PubMed. We chose PubMed because it contains more than 23 million publications and provides an interface that allows discovering novel publications as soon as they are made available. The user interface developed on top of the resulting datasets present an easily un-40 derstandable, integrated, up-to-date view of the information available in the back-end. The intuition behind our work is that when presented with such an interface, experts can detect unexpected correlations amongst known resources. These unex-45 pected correlations can then form the basis for a serendipitous discovery. For example, bio-medical experts that specialize on rare cancer types are empowered to easily detect the interactions between these rare cancer types and other diseases. For ex-50 ample, they could discover that certain cancer tends to metastasize into cancers of particular types, leading to the question of why this particular cell migration occurs. This question could then leads to the serendipitous formulation of new research ques-55 tions, e.g., pertaining to the rheology of certain cancer types.
The rest of this paper is structured as follows: We first give an overview of the architecture of our approach and show how it supports volume, velocity 60 and variability to generate novel value from large Linked Data datasets. We then present the user interface built on top of integrated datasets as well as outline various features of our interface. The evaluation section shows that our data infrastructure outperforms the state of the art in the management of large amounts of data. Moreover, it shows that our interface can be used easily. The conclusion of the paper presents future research avenues pertaining to Big Linked Data. Note that this paper is 70 based on the work presented in [2] .
Architecture
The architecture of our system is shown in Figure  1 and is explained in the following subsections.
Datasets
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Our framework relies on three types of datasets that are loaded into various SPARQL endpoints (explained in Section 2.2): Linked data version of TCGA, PubMed metadata in RDF and a set of mappings between these datasets. In the following,
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we describe each of these datasets in detail. and level 3 is processed data. Most of the analysis is performed on level 3 data 4 , therefore we selected level 3 data in this paper.
Exploiting such large amount of data in bioinformatics applications is a major challenge. One 100 has to download large archives and process the relevant text files in order to collect the actual data necessary for analysis. Further, data in the archives are not biologically linked and thus require lookups on various files. To overcome these issues, a Linked
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Data version of the Cancer Genome Atlas is developed [1] . The main aim of this work is to publish TCGA data as Linked Data and further made it publicly available through several SPARQL endpoints. This would enable researchers to issue a 110 query against a SPARQL endpoint and get the required chunk of data necessary for analysis. Such query processing capability saves a lot of time and encourage cancer researchers to develop real time applications on top of TCGA data. Currently,
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Linked TCGA contains 20.4 billion triples for 27 cancer diseases 5 . However, in this paper we have used data from 10 different cancer diseases (7.36 billion triples) of Linked TCGA. The details about data is given in 
TCGA Disease and Genes Mappings
The aim of the second dataset is to establish a bridge between the structured data contained in TCGA and the constant flow of RDF data generated by analyzing PubMed (see next subsec-125 tion). In order to integrate these two datasets, diseases and genes (including their synonyms) found in Linked TCGA are required to be identified in PubMed articles metadata. To achieve this goal, we extracted a list of diseases and genes from Linked 
Integrating PubMed Articles
Our third dataset consists of PubMed articles meta data. The purpose of this dataset is to keep our system up-to-date w.r.t. the current knowledge on the cancer types contained in the under- PubMed articles are not in RDF, we wrote our script which takes into a list of cancer-related keywords 8 which are used to search for PubMed articles tagged with those keywords. All articles returned 155 as a result based on set of keywords are transformed into RDF.
For searching purposes, we use the Entrez Programming Utilities (E-utilities) 9 which acts as an API to the Entrez system of databases at 160 the National Centre for Biotechnology Information (NCBI). The E-Utilities provides access to all major functions of Entrez, such as, text searching in databases (e.g., PubMed), downloading records in various formats etc. We use the E-Utilities API in 165 our script to search for PubMed article IDs associated with a particular keyword. We retrieve the full metadata record of article in the list of articles retrieved through the list of keywords. The resulting PubMed article information in XML for-170 mat is then transformed into RDF. Moreover, we analyze the abstract of each PubMed article retrieved previously to identify any disease or gene name using BANNER [3] . If a disease or a gene name is identified, we execute a SPARQL query on 175 our TCGA disease and gene mapping dataset (see section 2.1.2) to find matching resources. If the match is found, then we add a triple stating the relevance of a PubMed article to a particular disease or gene term using skos:related predicate.
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An excerpt of a PubMed article related to "bladder cancer" is shown in Listing 2.
TopFed
After creating the datasets for our framework, we had to ensure that the user interface is responsive 185 enough to be used in real use cases. Addressing 8 List of keywords obtained from https://tcga-data. nci.nih.gov/tcga/ 9 http://www.ncbi.nlm.nih.gov/books/NBK25501/ this scalability problem is one of the major challenges when developing this platform as it relies on a very large data basis. In particular, the Linked TCGA dataset contains over 20 billion triples and 190 is expected to reach around 30 billion triples as new data is being submitted frequently [1] . This is, to the best of our knowledge, the largest dataset of the Linked Open Data (LOD) Cloud. Hosting such large amount of data using a centralized server is 195 simply not scalable. We thus opted for using a total of 17 SPARQL endpoints to host the 30+ billion triples which resulted from our continuous integration of PudMed articles and LinkedTCGA. Each of the endpoint contains around 2 billion of triples
(load balancing). Still, querying this large amount of data is a tedious problem. Therefore, we addressed this problem by developing TopFed. TopFed is a Linked TCGA-tailored federated query engine for efficient on-the-fly data integration 205 from multiple TCGA SPARQL endpoints. Input SPARQL query is first processed to get the individual triple patterns. For each triple pattern, the set of relevant sources are obtained using the TopFed index which contains the data distribution informa-210 tion among TCGA SPARQL endpoints. The annotated query is then forwarded to the federator which generates multiple sub-queries. The output of the federator is forwarded to the optimizer, which generates an optimized query execution plan for the 215 Linked TCGA data. Each optimized sub-query is forwarded to the corresponding SPARQL endpoints and the results are integrated using the integrator. Finally, the integrated results are forwarded to the user. Complete details about TopFed can be found 220 at the project home page.
11
Current source selection [4, 5, 6] and SPARQL query federation [7, 8, 9] approaches are more general and do not leverage data distribution. Thus, 10 See section 2 for details: http://goo.gl/0oTAKV 11 https://code.google.com/p/topfed/ they overestimate the set of capable sources that ac-225 tually contribute to the final result set of SPARQL queries [6] . An over-estimation of sources can be very expensive while dealing with Big Linked Data sources such as the integrated Linked TCGA and PubMed datasets. In contrast, TopFed is an index-230 assisted approach particularly design for Linked TCGA and makes use of the intelligent data distribution provided as input 12 . Using a light-weight index, TopFed is able to detect the contributing sources for each SPARQL query and can thus re-235 duce the number of sources selected (without losing any recall) during the query federation. By selecting fewer sources than state-of-the-art approaches, our approach can compute the answer to queries significantly faster, leading to acceptable response 240 times for the queries required to use our framework.
Visualization
One of the most important challenges when delivering and using data-driven solutions for any type 12 TopFed Index: http://goo.gl/X6yz09 of human process is the provision of data visual-245 ization/summarization tools that are intuitive and easy to use for the experts [10] . Searching across integrated linked data sources, aggregating and displaying the evidence required to make informed decisions, and reusing the retrieved results to address 250 challenges in different contexts are the main tasks of such visual analytics platforms. The current method by which physicians look for information on the Web is through peer-reviewed publications. However, with the indexing of over 10,000 papers 255 in PubMed every year, keeping up-to-date with the literature and using this knowledge to derive new research questions has become a herculean task. To facilitate the intuitive exploration of the information available in TCGA datasets and tumor-related 260 publications, we coupled the integrated Linked TCGA and PubMed data with an interactive visual analytics platform called the Linked TCGA Dashboard. A prototype of the interface is available at http://srvgal78.deri.ie/tcga-pubmed/. 
Network Explorer
The Linked TCGA Dashboard comprises different perspectives through which the underlying inte- grated data sources can be explored. The Network Explorer perspective features a highly dense, force-270 directed network graph linking the different tumor typologies analyzed in TCGA to the publication resources where more information about these tumors can be discovered. The linking/display method retrieves tumor-associated publications and presents 275 them as a bipartite network graph initially (Fig. 3) , with the nodes colored according to the tumor mappings. On the selection of a publication node, the graph gets constrained to display the Mesh Terms associated with the selected publication resource.
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The relevant terms are displayed as distinct nodes along with other publication nodes which reference common Mesh terms (Fig. 2(B) ). The metadata of the publication (author, abstract, mesh terms, chemicals cited, etc.) is retrieved using a SPARQL 285 query and presented in the adjoining panel ( Fig.  2(C) ) along with a link to the original PubMed article.
Genome Browser
The phenomena of DNA Methylation is relevant 290 for cancer progression detection. Methylation patterns in cancer cells are known to reflect the silencing or "turning-off" of cancer protecting genes (i.e. tumor suppressor genes), thus allowing the cancer to progress. On the other hand, differential expres-295 sion of exons are used to build functional profiles, which provide insights into the underlying cellu- Each researcher can select the chromosome for 305 which he/she wishes to visualize the genomic datasets and the ideogrammatic representation of the selected chromosome is displayed in the first track (Fig. 4(A) ). Ideograms are a schematic representation to depict staining patterns on a 310 tightly-coiled chromosome. These Chromosome coordinates and descriptions of the Protein-coding genes contained within this chromosome are retrieved from CellBase [12] . These genes are annotated using the HGNC Nomenclature [13] and the positions are indicated by start/stop attributes, and 320 are shown in the subsequent track (Fig. 4(B) ). Hovering the mouse pointer above any gene provides additional information on this gene (Fig. 4(F) ). The cancer researcher has the option to select any tumor category and load the genomic datasets 325 of the patients diagnosed with that tumor using the interface controls ( (Fig. 4(E) ). Selection of the patient executes SPARQL queries against the corresponding Linked TCGA endpoints and retrieves his sequencing results in real-time. These datasets 330 (DNA Methylation and Exon Expression) are represented using bar charts (red and green respectively), whose X-coordinates are mapped to the genomic coordinates of the chromosome and the Y-coordinates indicate the normalized beta value 335 or the RKPM value at that chromosomal position. The Genome Browser perspective allows the simultaneous comparison of these results between different patients, and the corresponding genomic datasets are stacked vertically (Fig. 4(C,D) ). The 340 perspective also supports zooming and automatic 13 http://genome.ucsc.edu/ scrolling across the length of the clicked chromosome.
Technologies
The Linked TCGA Dashboard is a Web-based 
Use Cases
Our framework enables a variety of use cases, of which two are explained below.
Enabling Evidence-based genomic medicine
Data from TCGA is of high value for oncologists as it enables matching the evidence that they find for their own patients with those enrolled in the TCGA project, including both clinical and genomic sets. It is well known that specific genomic alterations in each individual's cancer affect response to treatment and sensitivity to drugs. As such, a physician could, for example, use our visualization to compare their own patient's methylation 380 patterns against that for other patients enrolled in TCGA. Since genomic information in TCGA is linked with each patient's clinical prognostic and follow-up, the physician could assert, based on the similarity of genomic results, whether a patient 385 would respond well to a given drug by observing the other patient's reaction. What this also enables is medical decisions that are highly informed by the evidence. Cancer, we now know, is a genetic disease. This means that the location where the 390 tumor occurs (e.g. brain, liver, etc) is less relevant for its treatment than the genetic signature that the cancer cells express (i.e. whether genes are silenced, amplified, etc). However, drugs that are approved by regulatory agencies, and many publication re-395 sources, are still approved in the context of a single tumor typology. By making use of cross-resource linking, we enable the discovery on whether a drug could be applied to more than on tumor typology, by linking the two typologies through their genomic 400 signature. As an example, a publication resource that is linked to two or more tumor typologies may mean that a discovery has been made that affects both cancer typologies and therefore the same drug or set of drugs may be applied. 
Generation of new hypotheses
In addition to aiding evidence based genomic medicine, the availability of this type of linked information can also facilitate inter-disciplinary research. Some types of cancer (e.g. breast can-410 cer) are more common than others and therefore the intricacies of their genomic signatures and genetic events tend to be more well known. However, for many rare cancers (e.g. pancreatic cancer), knowledge is more scattered and harder to find.
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The resource that we make available will enable researchers in the less common tumor typologies to discover association between their cancer of interest, and those that are more well studied. By finding papers where two tumor typologies co-occur, a 420 researcher can hypothesize that the treatments and genomic events that are valid and have been proved to be relevant in the most common type of cancer, may also be relevant in the less common tumor typology. They can then exploit the genomic data in 425 both cases to support or reject this hypothesis.
Another possible arena for hypothesis generation is that of tumor cell migration. Cancer experts have shown in the past that, for some tumor typologies, metastasis occurs preferentially in a spe-430 cific tissue type. This is known as the "seed-andsoil" hypothesis, meaning that cancer cell "seeds" travelling in the blood vessels prefer some specific tissues to metastasize as they are optimal "soil" for their growth. For example, skin tumor cells pref-435 erentially metastasize in the brain. As such, cooccurrence of tumor typologies in publications may mean that cells of a particular tumor typology that is the main subject of a publication, preferentially migrate to the tissue of the second tumor typology, 440 co-occurring in the publication but not necessarily the main subject of the paper.
Evaluation
The goal of our evaluation is (1) to evaluate the accuracy of Linked TCGA integration with 445 PubMed articles, (2) measure the performance of TopFed engine in terms of smart source selection and query execution time, and (3) to quantify the usability and usefulness of our visualisation. In the following, we explain our experimental setup and 450 the evaluation results.
Experimental Setup
The aim of the TopFed evaluation is to show that it is well suited for the management of large volumes of Linked Data and can consequently support 455 the extension of this data by novel RDF data extracted from other data streams. We thus compared TopFed with FedX [7] on 25 patients genomic results (clinical, methylation, SNP, exonexpression, gene-expression, miRNA, RNAseq2) ex-460 tracted from 10 tumors. All of the data was distributed across 10 local SPARQL endpoints sharing a dedicated network. We considered 10 queries of which 4 were star-shaped [6] and the remaining queries were path-shaped or hybrid (path+star) 465 and contained between 3 and 7 triple patterns. We ran each of the queries 10 times and present the average runtime for each of the queries. The query evaluation experiments were carried out on a 2.53GHz i5 processor with 4GB RAM. All of the 470 data along with queries used for our evaluation can be found at TopFed home page. 16 
Results
Data integration
In order to compute the precision of PubMed ar-475 ticles integration with Linked TCGA, we randomly selected 50 publications related to genes and cancer tumors from PubMed. Using our custom written scripts, we converted these articles to RDF and further evaluated the links generated using BANNER
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between genes and cancer diseases within those articles. For the evaluation, 3 biologists reviewed each link manually. After the manual inspection, the results of the evaluators showed that using BANNER, we have achieved a precision of 63% for TCGA 485 cancer disease and 84% for TCGA genes while integrating PubMed article's metadata with Linked TCGA. Figure 5 shows the query runtime of TopFed
Query Runtime Performance
490
and FedX. As an overall performance evaluation, TopFed is able to select half of the source to FedX without losing the recall. Consequently, the query run time of TopFed is about one third to that of FedX. we outperform FedX significantly on 90% of 495 the queries. In the base case (query 2, query 3), TopFed is more than 75 times faster than FedX. We only have the same runtime for query 5. This is simply due to the number of sources selected by FedX being already optimal. Thus, our source 500 selection approach selects exactly the same data sources. Due to smart source selection, we believe that our approach scales well on a large datasets.
Usability and Usefulness
To assess the usability of our visualisation, we 505 used the standardized, ten-item Likert scale-based System Usability Scale (SUS) [15] In addition, we conducted a custom survey 18 to asses the usefulness of our system in terms of various functionalities provided in the visualization.
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Both of these survey were filled by the same 3 biologists who evaluated the accuracy of PubMed articles integration with Linked TCGA. The results of SUS usability survey is shown in Figure 6 . We achieved a mean usability score of 77 indicating a 515 high level of usability according to the SUS score. The responses to question 10 suggests that our system is adequate for frequent use (average score to question 10 = 4.33 ± 0.57) by users all of type (4.33 ± 0.57 average score for question 4). The results of 520 the usefulness of our visualisation is shown in Figure  7 . As an overall usefulness evaluation, we achieved an average score of 3.52/5 indicating a usefulness of 70.37 %. In particular, we achieved an average score of 3.83/5 (76.66 %) for the use cases discussed 525 in Section 4.
Conclusion and Future Work
In this paper, we presented a scalable Linked Data-driven solution for the continuous integration of bio-medical data sources i.e., LinkedTCGA and 530 PubMed. We also propose a visual environment that enable researchers to easily understand the data and support the serendipitous discovery of biomedical hypotheses. The evaluation of our system leads us to believe that is usable and useful for bio- I think that I would like to use this system frequently I found the system unnecessarily complex I thought the system was easy to use I think that I would need the support of a technical person to be able to use this system I found the various functions in this system were well integrated I thought there was too much inconsistency in this system I would imagine that most people would learn to use this system very quickly I found the system very cumbersome to use I felt very confident using the system I needed to learn a lot of things before I could get going with this system Chart Title
Avg. STD. How easy is it to analyze a particular publication associated with a tumor?
How relevant is the tabular summary of publication for your daily research?
How comfortable is the navigation through the Mesh Terms?
How easy is it to visualize cancer patient data for a particular chromosome?
How frequently do you use Genome Browsers for your daily research?
How easy is our Genome visualization to use comparing to other popular Genome Browsers?
How would you categorize your experience while using our visualization Dashboard?
How useful is our visualization in enabling evidence-based genomic medicine?
How useful is our visualization in generation of new hypothesis?
Chart Title
Avg. STD. which embodies the novel 'Genomic Wheel' visu-540 alisation for the human genome within the Linked TCGA Dashboard. By these means, we will enable cancer researchers to easily isolate genomic segments of interest and analyse the genomic datasets of the Linked TCGA patients in their context.
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